Your Cart ( 1 Item )

• Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study
  March 2018 | Volume 17 | Issue 3 | Case Reports | 333 | Copyright © March 2018
  James J. Leyden MD,^a Vilma Sniukiene MD,^b David R. Berk MD,^b and Alexandre Kaoukhov MD^b
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs